Rania Abdelmessih
About Rania Abdelmessih
Rania Abdelmessih is the Executive Director of VAP & HEOR, Strategy & Operations at Bristol Myers Squibb in Princeton, New Jersey, with over 15 years of experience in medical information, market access, and global strategy.
Current Title and Role
Rania Abdelmessih currently serves as the Executive Director, VAP & HEOR, Strategy & Operations at Bristol Myers Squibb in Princeton, New Jersey, United States. In this role, she oversees Value, Access, and Pricing (VAP) and Health Economics and Outcomes Research (HEOR) strategies and operations for the company.
Past Professional Experience
Rania Abdelmessih has over 15 years of experience at Bristol Myers Squibb in various roles. She previously held positions such as Director, Global Access Strategy Immuno-oncology, and Associate Director, Global Market Access Immuno-Oncology. Her career also includes roles in US Market Access, Market Access Management for the Intercontinental Region, and several managerial roles in medical information covering metabolic, cardiovascular, and immunoscience areas.
Education and Expertise
Rania Abdelmessih earned a Doctor of Pharmacy (PharmD) from Rutgers University-New Brunswick, where she studied from 2000 to 2006. She also holds a Master of Business Administration (M.B.A.) from Seton Hall University, completed between 2009 and 2011. Her robust educational background supports her extensive career in medical information, market access, and global strategy.
Specialization in Immuno-oncology
Rania Abdelmessih has significant experience in the field of immuno-oncology, having held multiple roles related to global access strategy and market access in this specialized area. Her work has involved developing and implementing strategies to maximize global access to immuno-oncology therapies.
Market Access Strategies
One of Rania Abdelmessih's key areas of expertise is market access strategies, especially for regions such as Latin America, the Middle East, and Africa. She has developed and executed market access frameworks that aim to improve the availability and affordability of healthcare solutions in these diverse markets.